BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 30971235)

  • 1. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Naccache JM; Jouneau S; Didier M; Borie R; Cachanado M; Bourdin A; Reynaud-Gaubert M; Bonniaud P; Israël-Biet D; Prévot G; Hirschi S; Lebargy F; Marchand-Adam S; Bautin N; Traclet J; Gomez E; Leroy S; Gagnadoux F; Rivière F; Bergot E; Gondouin A; Blanchard E; Parrot A; Blanc FX; Chabrol A; Dominique S; Gibelin A; Tazi A; Berard L; Brillet PY; Debray MP; Rousseau A; Kerjouan M; Freynet O; Dombret MC; Gamez AS; Nieves A; Beltramo G; Pastré J; Le Borgne-Krams A; Dégot T; Launois C; Plantier L; Wémeau-Stervinou L; Cadranel J; Chenivesse C; Valeyre D; Crestani B; Cottin V; Simon T; Nunes H;
    Lancet Respir Med; 2022 Jan; 10(1):26-34. PubMed ID: 34506761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Kangxian Huanji Granule as adjunctive treatment in acute exacerbation of idiopathic pulmonary fibrosis: An exploratory randomized controlled trial.
    Li JS; Zhang HL; Guo W; Wang L; Zhang D; Zhao LM; Zhou M
    J Integr Med; 2023 Nov; 21(6):543-549. PubMed ID: 37993378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial.
    Hailong Z; Jiansheng L; Wen G; Lu W; Dong Z; Limin Z; Miao Z; Weixian L
    Trials; 2022 Feb; 23(1):103. PubMed ID: 35109889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
    Richeldi L
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
    Hozumi H; Hasegawa H; Miyashita K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Respirology; 2019 Aug; 24(8):792-798. PubMed ID: 30803100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: a single center experience and literature review.
    Novelli L; Ruggiero R; De Giacomi F; Biffi A; Faverio P; Bilucaglia L; Gamberini S; Messinesi G; Pesci A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):385-391. PubMed ID: 28079851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
    Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
    Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
    Kuse N; Abe S; Hayashi H; Kamio K; Saito Y; Usuki J; Azuma A; Kudoh S; Gemma A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):242-246. PubMed ID: 27758989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
    Furuya K; Sakamoto S; Shimizu H; Sekiya M; Kinoshita A; Isshiki T; Sugino K; Matsumoto K; Homma S
    Respir Med; 2017 May; 126():93-99. PubMed ID: 28427556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
    Ryerson CJ; Cottin V; Brown KK; Collard HR
    Eur Respir J; 2015 Aug; 46(2):512-20. PubMed ID: 26232481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.
    Hammond M; Clark AB; Cahn AP; Chilvers ER; Fraser WD; Livermore DM; Maher TM; Parfrey H; Swart AM; Stirling S; Thickett D; Whyte M; Wilson A
    Trials; 2018 Feb; 19(1):89. PubMed ID: 29402332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis.
    Richeldi L; Cottin V; Flaherty KR; Kolb M; Inoue Y; Raghu G; Taniguchi H; Hansell DM; Nicholson AG; Le Maulf F; Stowasser S; Collard HR
    Respir Med; 2014 Jul; 108(7):1023-30. PubMed ID: 24834811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.
    Behr J; Nathan SD; Harari S; Wuyts W; Kirchgaessler KU; Bengus M; Gilberg F; Wells AU
    Respir Med; 2018 May; 138():13-20. PubMed ID: 29724385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.
    Farrand E; Vittinghoff E; Ley B; Butte AJ; Collard HR
    Respirology; 2020 Jun; 25(6):629-635. PubMed ID: 31846126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.
    Ley B; Swigris J; Day BM; Stauffer JL; Raimundo K; Chou W; Collard HR
    Am J Respir Crit Care Med; 2017 Sep; 196(6):756-761. PubMed ID: 28471697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis.
    Sakamoto S; Homma S; Miyamoto A; Kurosaki A; Fujii T; Yoshimura K
    Intern Med; 2010; 49(2):109-15. PubMed ID: 20075573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?
    Cuerpo S; Moisés J; Hernández-González F; Benegas M; Ramirez J; Sánchez M; Agustí À; Sellares J
    Chron Respir Dis; 2019; 16():1479973119869334. PubMed ID: 31431063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
    Dotan Y; Vaidy A; Shapiro WB; Zhao H; Dass C; Toyoda Y; Marchetti N; Shenoy K; Cordova FC; Criner GJ; Mamary AJ
    Chest; 2018 Oct; 154(4):818-826. PubMed ID: 29966665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.